Study aims to spare breast cancer patients from unnecessary chemo
NCT ID NCT03820063
Summary
This study is testing a personalized approach to chemotherapy for HER2-positive breast cancer. It aims to see if doctors can safely give fewer chemotherapy cycles to patients who show a strong, early response to treatment on an MRI scan. The goal is to reduce side effects while still effectively controlling the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alexander Monro ziekenhuis
Bilthoven, Netherlands
-
Amphia Ziekenhuis
Breda, Netherlands
-
Amsterdam UMC
Amsterdam, Netherlands
-
Bernhoven
Oss, Netherlands
-
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands
-
Catharina ziekenhuis
Eindhoven, Netherlands
-
Deventer ziekenhuis
Deventer, Netherlands
-
Diakonessenhuis Utrecht
Utrecht, Netherlands
-
Elisabeth TweeSteden ziekenhuis
Tilburg, Netherlands
-
Elkerliek ziekenhuis
Helmond, Netherlands
-
Erasmus MC, Universitair Medisch Centrum Rotterdam
Rotterdam, Netherlands
-
Franciscus Gasthuis en Vlietland
Rotterdam, Netherlands
-
Gelre ziekenhuizen
Apeldoorn, Netherlands
-
Groene Hart Ziekenhuis
Gouda, Netherlands
-
Haaglanden MC
The Hague, Netherlands
-
Haga Ziekenhuis
The Hague, Netherlands
-
Ikazia Ziekenhuis
Rotterdam, Netherlands
-
Isala Klinieken
Zwolle, Netherlands
-
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, Netherlands
-
Laurentius ziekenhuis
Roermond, Netherlands
-
MUMC
Maastricht, Netherlands
-
Maasstadziekenhuis
Rotterdam, Netherlands
-
Martini ziekenhuis
Groningen, Netherlands
-
Maxima Medisch Centrum
Eindhoven, Netherlands
-
Meander Medisch Centrum
Amersfoort, Netherlands
-
Medisch Centrum Leeuwarden
Leeuwarden, Netherlands
-
NKI-AVL
Amsterdam, Netherlands
-
Nij Smellinghe
Drachten, Netherlands
-
Noordwest Ziekenhuisgroep
Alkmaar, Netherlands
-
OLVG
Amsterdam, Netherlands
-
RIVAS Beatrixziekenhuis
Gorinchem, Netherlands
-
Reinier de Graaf Groep
Delft, Netherlands
-
Rijnstate
Arnhem, Netherlands
-
Rivierenland Ziekenhuis
Tiel, Netherlands
-
Rode Kruis Ziekenhuis
Beverwijk, Netherlands
-
SKB Ziekenhuis Winterswijk
Winterswijk, Netherlands
-
Sint Annaziekenhuis
Geldrop, Netherlands
-
Sint Antonius ziekenhuis
Nieuwegein, Netherlands
-
Spaarne Gasthuis
Hoofddorp, Netherlands
-
Stichting ziekenhuizen West-Friesland en Waterland
Purmerend, Netherlands
-
Tergooi
Hilversum, Netherlands
-
Tjongerschans
Heerenveen, Netherlands
-
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
-
VieCurie Medisch Centrum voor Noord-Limburg
Venlo, Netherlands
-
Zaans Medisch Centrum
Zaandam, Netherlands
-
Ziekenhuis Amstelland
Amstelveen, Netherlands
-
Ziekenhuis St. Jansdal
Harderwijk, Netherlands
-
Ziekenhuisgroep Twente
Almelo, Netherlands
-
Ziekenhuisvoorziening Gelderse Vallei
Ede, Netherlands
-
ZorgSaam
Terneuzen, Netherlands
-
Zuyderland Medisch Centrum
Heerlen, Netherlands
-
van Weel Bethesda
Dirksland, Netherlands
Conditions
Explore the condition pages connected to this study.